Exact Mass: 461.2194
Exact Mass Matches: 461.2194
Found 500 metabolites which its exact mass value is equals to given mass value 461.2194
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pimozide
A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to haloperidol for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AG - Diphenylbutylpiperidine derivatives D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Pimozide is a dopamine receptor antagonist, with Kis of 1.4 nM, 2.5 nM and 588 nM for dopamine D2, D3 and D1 receptors, respectively, and also has affinity at α1-adrenoceptor, with a Ki of 39 nM; Pimozide also inhibits STAT3 and STAT5.
Bitolterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents
((2,6-Bis(1-methylethyl)phenoxy)sulfonyl)carbamic acid 2,6-bis(1-methylethyl)phenyl ester
Glu Ala Lys Asp
Ser Val Gln Glu
Ala Asp Thr Arg
Lys Ala Glu Asp
Ala Glu Lys Asp
Thr Asn Ile Asp
Thr Gln Val Asp
Arg Ser Ala Glu
Ser Gln Ile Asp
Lys Asp Ala Glu
pimozide
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AG - Diphenylbutylpiperidine derivatives D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3862; ORIGINAL_PRECURSOR_SCAN_NO 3860 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3823; ORIGINAL_PRECURSOR_SCAN_NO 3820 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3854; ORIGINAL_PRECURSOR_SCAN_NO 3850 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8187; ORIGINAL_PRECURSOR_SCAN_NO 8184 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8258; ORIGINAL_PRECURSOR_SCAN_NO 8257 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8218; ORIGINAL_PRECURSOR_SCAN_NO 8216 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8255; ORIGINAL_PRECURSOR_SCAN_NO 8253 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8237; ORIGINAL_PRECURSOR_SCAN_NO 8235 CONFIDENCE standard compound; INTERNAL_ID 205; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8257; ORIGINAL_PRECURSOR_SCAN_NO 8255 Pimozide is a dopamine receptor antagonist, with Kis of 1.4 nM, 2.5 nM and 588 nM for dopamine D2, D3 and D1 receptors, respectively, and also has affinity at α1-adrenoceptor, with a Ki of 39 nM; Pimozide also inhibits STAT3 and STAT5.
Ala Asp Glu Lys
Ala Asp Lys Glu
Ala Asp Arg Thr
Ala Glu Asp Lys
Ala Glu Arg Ser
Ala Glu Ser Arg
Ala Phe Pro Gln
Ala Phe Gln Pro
Ala Lys Asp Glu
Ala Lys Glu Asp
Ala Pro Phe Gln
Ala Pro Gln Phe
Ala Gln Phe Pro
Ala Gln Pro Phe
Ala Arg Asp Thr
Ala Arg Glu Ser
Ala Arg Ser Glu
Ala Arg Thr Asp
Ala Ser Glu Arg
Ala Ser Arg Glu
Ala Ser Val Trp
Ala Ser Trp Val
Ala Thr Asp Arg
Ala Thr Arg Asp
Ala Val Ser Trp
Ala Val Trp Ser
Ala Trp Ser Val
Ala Trp Val Ser
Asp Ala Glu Lys
Asp Ala Lys Glu
Asp Ala Arg Thr
Asp Ala Thr Arg
Asp Glu Ala Lys
Asp Glu Lys Ala
Asp Ile Asn Thr
Asp Ile Gln Ser
Asp Ile Ser Gln
Asp Ile Thr Asn
Asp Lys Ala Glu
Asp Lys Glu Ala
Asp Leu Asn Thr
Asp Leu Gln Ser
Asp Leu Ser Gln
Asp Leu Thr Asn
Asp Asn Ile Thr
Asp Asn Leu Thr
Asp Asn Thr Ile
Asp Asn Thr Leu
Asp Gln Ile Ser
Asp Gln Leu Ser
Asp Gln Ser Ile
Asp Gln Ser Leu
Asp Gln Thr Val
Asp Gln Val Thr
Asp Arg Ala Thr
Asp Arg Thr Ala
Asp Ser Ile Gln
Asp Ser Leu Gln
Asp Ser Gln Ile
Asp Ser Gln Leu
Asp Thr Ala Arg
Asp Thr Ile Asn
Asp Thr Leu Asn
Asp Thr Asn Ile
Asp Thr Asn Leu
Asp Thr Gln Val
Asp Thr Arg Ala
Asp Thr Val Gln
Asp Val Gln Thr
Asp Val Thr Gln
Glu Ala Asp Lys
Glu Ala Arg Ser
Glu Ala Ser Arg
Glu Asp Ala Lys
Glu Asp Lys Ala
Glu Glu Gly Lys
Glu Glu Lys Gly
Glu Gly Glu Lys
Glu Gly Lys Glu
Glu Gly Arg Thr
Glu Gly Thr Arg
Glu Ile Asn Ser
Glu Ile Ser Asn
Glu Lys Ala Asp
Glu Lys Asp Ala
Glu Lys Glu Gly
Glu Lys Gly Glu
Glu Leu Asn Ser
Glu Leu Ser Asn
Glu Asn Ile Ser
Glu Asn Leu Ser
Glu Asn Ser Ile
Glu Asn Ser Leu
Glu Asn Thr Val
Glu Asn Val Thr
Glu Gln Ser Val
Glu Gln Val Ser
Glu Arg Ala Ser
Glu Arg Gly Thr
Glu Arg Ser Ala
Glu Arg Thr Gly
Glu Ser Ala Arg
Glu Ser Ile Asn
Glu Ser Leu Asn
Glu Ser Asn Ile
Glu Ser Asn Leu
Glu Ser Gln Val
Glu Ser Arg Ala
Glu Ser Val Gln
Glu Thr Gly Arg
Glu Thr Asn Val
Glu Thr Arg Gly
Glu Thr Val Asn
Glu Val Asn Thr
Glu Val Gln Ser
Glu Val Ser Gln
Glu Val Thr Asn
Phe Ala Pro Gln
Phe Ala Gln Pro
Phe Pro Ala Gln
Phe Pro Gln Ala
Phe Gln Ala Pro
Phe Gln Pro Ala
Gly Glu Glu Lys
Gly Glu Lys Glu
Gly Glu Arg Thr
Gly Glu Thr Arg
Gly Ile Ser Trp
Gly Ile Trp Ser
Gly Lys Glu Glu
Gly Leu Ser Trp
Gly Leu Trp Ser
Gly Arg Glu Thr
Gly Arg Thr Glu
Gly Ser Ile Trp
Gly Ser Leu Trp
Gly Ser Trp Ile
Gly Ser Trp Leu
Gly Thr Glu Arg
Gly Thr Arg Glu
Gly Thr Val Trp
Gly Thr Trp Val
Gly Val Thr Trp
Gly Val Trp Thr
Gly Trp Ile Ser
Gly Trp Leu Ser
Gly Trp Ser Ile
Gly Trp Ser Leu
Gly Trp Thr Val
Gly Trp Val Thr
Ile Asp Asn Thr
Ile Asp Gln Ser
Ile Asp Ser Gln
Ile Asp Thr Asn
Ile Glu Asn Ser
Ile Glu Ser Asn
Ile Gly Ser Trp
Ile Gly Trp Ser
Ile Asn Asp Thr
Ile Asn Glu Ser
Ile Asn Ser Glu
Ile Asn Thr Asp
Ile Gln Asp Ser
Ile Gln Ser Asp
Ile Ser Asp Gln
Ile Ser Glu Asn
Ile Ser Gly Trp
Ile Ser Asn Glu
Ile Ser Gln Asp
Ile Ser Trp Gly
Ile Thr Asp Asn
Ile Thr Asn Asp
Ile Trp Gly Ser
Ile Trp Ser Gly
Lys Ala Asp Glu
Lys Asp Glu Ala
Lys Glu Ala Asp
Lys Glu Asp Ala
Lys Glu Glu Gly
Lys Glu Gly Glu
Lys Gly Glu Glu
Lys Asn Asn Ser
Lys Asn Ser Asn
Lys Ser Asn Asn
Leu Asp Asn Thr
Leu Asp Gln Ser
Leu Asp Ser Gln
Leu Asp Thr Asn
Leu Glu Asn Ser
Leu Glu Ser Asn
Leu Gly Ser Trp
Leu Gly Trp Ser
Leu Asn Asp Thr
Leu Asn Glu Ser
Leu Asn Ser Glu
Leu Asn Thr Asp
Leu Gln Asp Ser
Leu Gln Ser Asp
Leu Ser Asp Gln
Leu Ser Glu Asn
Leu Ser Gly Trp
Leu Ser Asn Glu
Leu Ser Gln Asp
Leu Ser Trp Gly
Leu Thr Asp Asn
Leu Thr Asn Asp
Leu Trp Gly Ser
Leu Trp Ser Gly
Asn Asp Ile Thr
Asn Asp Leu Thr
Asn Asp Thr Ile
Asn Asp Thr Leu
Asn Glu Ile Ser
Asn Glu Leu Ser
Asn Glu Ser Ile
Asn Glu Ser Leu
Asn Glu Thr Val
Asn Glu Val Thr
Asn Ile Asp Thr
Asn Ile Glu Ser
Asn Ile Ser Glu
Asn Ile Thr Asp
Asn Lys Asn Ser
Asn Lys Ser Asn
Asn Leu Asp Thr
Asn Leu Glu Ser
Asn Leu Ser Glu
Asn Leu Thr Asp
Asn Asn Lys Ser
Asn Asn Ser Lys
Asn Ser Glu Ile
Asn Ser Glu Leu
Asn Ser Ile Glu
Asn Ser Lys Asn
Asn Ser Leu Glu
Asn Ser Asn Lys
Asn Thr Asp Ile
Asn Thr Asp Leu
Asn Thr Glu Val
Asn Thr Ile Asp
Asn Thr Leu Asp
Asn Thr Val Glu
Asn Val Glu Thr
Asn Val Thr Glu
Pro Ala Phe Gln
Pro Ala Gln Phe
Pro Phe Ala Gln
Pro Phe Gln Ala
Pro Gln Ala Phe
Pro Gln Phe Ala
Gln Ala Phe Pro
Gln Ala Pro Phe
Gln Asp Ile Ser
Gln Asp Leu Ser
Gln Asp Ser Ile
Gln Asp Ser Leu
Gln Asp Thr Val
Gln Asp Val Thr
Gln Glu Ser Val
Gln Glu Val Ser
Gln Phe Ala Pro
Gln Phe Pro Ala
Gln Ile Asp Ser
Gln Ile Ser Asp
Gln Leu Asp Ser
Gln Leu Ser Asp
Gln Pro Ala Phe
Gln Pro Phe Ala
Gln Ser Asp Ile
Gln Ser Asp Leu
Gln Ser Glu Val
Gln Ser Ile Asp
Gln Ser Leu Asp
Gln Ser Val Glu
Gln Thr Asp Val
Gln Thr Val Asp
Gln Val Asp Thr
Gln Val Glu Ser
Gln Val Ser Glu
Gln Val Thr Asp
Arg Ala Asp Thr
Arg Ala Glu Ser
Arg Ala Ser Glu
Arg Ala Thr Asp
Arg Asp Ala Thr
Arg Asp Thr Ala
Arg Glu Ala Ser
Arg Glu Gly Thr
Arg Glu Ser Ala
Arg Glu Thr Gly
Arg Gly Glu Thr
Arg Gly Thr Glu
Arg Ser Glu Ala
Arg Thr Ala Asp
Arg Thr Asp Ala
Arg Thr Glu Gly
Arg Thr Gly Glu
Ser Ala Glu Arg
Ser Ala Arg Glu
Ser Ala Val Trp
Ser Ala Trp Val
Ser Asp Ile Gln
Ser Asp Leu Gln
Ser Asp Gln Ile
Ser Asp Gln Leu
Ser Glu Ala Arg
Ser Glu Ile Asn
Ser Glu Leu Asn
Ser Glu Asn Ile
Ser Glu Asn Leu
Ser Glu Gln Val
Ser Glu Arg Ala
Ser Glu Val Gln
Ser Gly Ile Trp
Ser Gly Leu Trp
Ser Gly Trp Ile
Ser Gly Trp Leu
Ser Ile Asp Gln
Ser Ile Glu Asn
Ser Ile Gly Trp
Ser Ile Asn Glu
Ser Ile Gln Asp
Ser Ile Trp Gly
Ser Lys Asn Asn
Ser Leu Asp Gln
Ser Leu Glu Asn
Ser Leu Gly Trp
Ser Leu Asn Glu
Ser Leu Gln Asp
Ser Leu Trp Gly
Ser Asn Glu Ile
Ser Asn Glu Leu
Ser Asn Ile Glu
Ser Asn Lys Asn
Ser Asn Leu Glu
Ser Asn Asn Lys
Ser Gln Asp Ile
Ser Gln Asp Leu
Ser Gln Glu Val
Ser Gln Leu Asp
Ser Gln Val Glu
Ser Arg Ala Glu
Ser Arg Glu Ala
Ser Val Ala Trp
Ser Val Glu Gln
Ser Val Trp Ala
Ser Trp Ala Val
Ser Trp Gly Ile
Ser Trp Gly Leu
Ser Trp Ile Gly
Ser Trp Leu Gly
Ser Trp Val Ala
Thr Ala Asp Arg
Thr Ala Arg Asp
Thr Asp Ala Arg
Thr Asp Ile Asn
Thr Asp Leu Asn
Thr Asp Asn Ile
Thr Asp Asn Leu
Thr Asp Gln Val
Thr Asp Arg Ala
Thr Asp Val Gln
Thr Glu Gly Arg
Thr Glu Asn Val
Thr Glu Arg Gly
Thr Glu Val Asn
Thr Gly Glu Arg
Thr Gly Arg Glu
Thr Gly Val Trp
Thr Gly Trp Val
Thr Ile Asp Asn
Thr Ile Asn Asp
Thr Leu Asp Asn
Thr Leu Asn Asp
Thr Asn Asp Ile
Thr Asn Asp Leu
Thr Asn Glu Val
Thr Asn Leu Asp
Thr Asn Val Glu
Thr Gln Asp Val
Thr Arg Ala Asp
Thr Arg Asp Ala
Thr Arg Glu Gly
Thr Arg Gly Glu
Thr Val Asp Gln
Thr Val Glu Asn
Thr Val Gly Trp
Thr Val Asn Glu
Thr Val Gln Asp
Thr Val Trp Gly
Thr Trp Gly Val
Thr Trp Val Gly
Val Ala Ser Trp
Val Ala Trp Ser
Val Asp Gln Thr
Val Asp Thr Gln
Val Glu Asn Thr
Val Glu Gln Ser
Val Glu Ser Gln
Val Glu Thr Asn
Val Gly Thr Trp
Val Gly Trp Thr
Val Asn Glu Thr
Val Asn Thr Glu
Val Gln Asp Thr
Val Gln Glu Ser
Val Gln Ser Glu
Val Gln Thr Asp
Val Ser Ala Trp
Val Ser Glu Gln
Val Ser Gln Glu
Val Ser Trp Ala
Val Thr Asp Gln
Val Thr Glu Asn
Val Thr Gly Trp
Val Thr Asn Glu
Val Thr Gln Asp
Val Thr Trp Gly
Val Trp Ala Ser
Val Trp Gly Thr
Val Trp Ser Ala
Val Trp Thr Gly
Trp Ala Ser Val
Trp Ala Val Ser
Trp Gly Ile Ser
Trp Gly Leu Ser
Trp Gly Ser Ile
Trp Gly Ser Leu
Trp Gly Thr Val
Trp Gly Val Thr
Trp Ile Gly Ser
Trp Ile Ser Gly
Trp Leu Gly Ser
Trp Leu Ser Gly
Trp Ser Ala Val
Trp Ser Gly Ile
Trp Ser Gly Leu
Trp Ser Ile Gly
Trp Ser Leu Gly
Trp Ser Val Ala
Trp Thr Gly Val
Trp Thr Val Gly
Trp Val Ala Ser
Trp Val Gly Thr
Trp Val Ser Ala
Trp Val Thr Gly
Bms-754807
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Dasolampanel etibutil
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
N-[(2S,6R)-2-[(L-Ala-D-gammaGlu-)Amino]-6-amino-6-carboxyhexanoyl]-D-Ala-OH
N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide
(2S)-2-amino-N-(2,6-dimethylphenyl)-N-(3-pyridin-3-ylpropyl)propanamide;(2R,3R)-2,3-dihydroxybutanedioic acid
(1S,9R,10R,11R)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1R)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-12-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1S)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-12-benzyl-5-(3-fluorophenyl)-10-(hydroxymethyl)-N,N-dimethyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(2-fluorophenyl)-10-(hydroxymethyl)-12-methyl-6-oxo-N-[(1R)-1-phenylethyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
Bitolterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents